Design and patient characteristics of ESHOL study, a Catalonian prospective randomized study

Journal of Nephrology

Volumn 24, Issue 2, 2011, Pages 196-202

  Maduell, Francisco ^a   Moreso, Francesc ^b   Pons, Mercedes ^c   Ramos, Rosa ^d   Mora Macià, Josep ^e   Foraster, Andreu ^f   Soler, Jordi ^g   Galceran, Josep M ^h   Martinez Castelao, Alberto ⁱ  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c CETIRSA   (Spain)

^d Hospital San Antonio Abad   (Spain)

^e Fresenius Medical Care   (Spain)

^f Diaverum Baix Llobregat   (Spain)

^g Fresenius Medical Care   (Spain)

^h Althaia   (Spain)

ⁱ HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Convective therapies; Dialysis adequacy; Mortality; On line hemodiafiltration

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; ONLINE SYSTEM; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SAMPLE SIZE; SPAIN; STUDY DESIGN; SURVIVAL TIME;

EID: 79953715945     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2010.386     Document Type: Article

References (27)

1. Registre Malalts Renals de Catalunya. Informe estadístic 2005-2006. Available at: http://www10.gencat.cat/catsalut/ocatt/pdfs/Info_renal_2005_2006.
2. Registro Español de Enfermes Renales. Informe de 2006 de diálisis y trasplante renal es España. Nefrologia. 2009;29:525-533.
3. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010-2019.
4. Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20:645-654.
5. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schütterle G. Hemodiafiltration: a new alternative to hemofiltration and conventional hemodialysis. Artif Organs. 1978;2:150-153.
6. Wizemann V, Kramer W, Knopp G, Rawer P, Mueller K, Schütterle G. Ultrashort hemodiafiltration: efficiency and hemodynamic tolerance. Clin Nephrol. 1983;19:24-30.
7. Cioni L, Palmarini D, Pilone N, Rindi P. High-flux hemodiafiltration: 5 years experience. Blood Purif. 1989;7:197-202.
8. Santoro A, Ferrari G, Spongano M, Badiali F, Zuchelli P. Acetate free biofiltration: a viable alternative to bicarbonate dialysis. Artif Organs. 1989;13:476-479.
9. Canaud B, Flavier JL, Argiles A, et al. Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy. Contrib Nephrol. 1994;108:12-22.
10. Locatelli F, Marcelli D, Conte F, et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. Kidney Int. 1999;55:286-293.
11. Maduell F, Pozo C, Garcia H, et al. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant. 1999;14:1202-1207.
12. Lornoy W, Becaus L, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P. On-line haemodiafiltration: remarkable removal of β2-microglobulin: long term observations. Nephrol Dial Transplant. 2000;15(Suppl 1):49-54.
13. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol. 2000;11:2344-2350.
14. Wizemann V, Lotz C, Techert F, Uthoff S. On-line haemodiafiltration versus low-flux hemodialysis: a prospective randomized study. Nephrol Dial Transplant. 2000;15(Suppl 1):S43-S48.
15. Carracedo J, Merino A, Nogueras S, et al. On-line hemodiafiltration reduces the proinflammatory CD14+ CD16+ monocyte-derived dendritic cells: a prospective, crossover study. J Am Soc Nephrol. 2006;17:2315-2321.
16. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006;69:2087-2093.
17. Jirka T, Cesare S, Di Benedetto A, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int. 2006;70:1524-1525.
18. Panichi V, Rizza GM, Paoletti S, et al. Chronic inflammation and mortality in haemodialysis: effect of different replacement therapies: results from the RISCAVID study. Nephrol Dial Transplant. 2008;23:2337-2343.
19. Hospital Clinic of Barcelona. Survival Study in Patients Undergoing On-line Hemodiafiltration (ESHOL): a Randomized Study to Evaluate Survival in Patients Undergoing Hemodialysis or On-line Hemodiafiltration. ClinicalTrials.gov, NIH. Available at: http://clinicaltrials.gov/ct2/show/NCT00694031. Accessed April 30, 2010.
20. Hemmelgarn BR, Manns BJ, Quan H, et al. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003;42:125-132.
21. Tattersall J, Martin-Malo A, Pedrini L, et al. EBPG guideline on dialysis strategies. Nephrol Dial Transplant. 2007;22(Suppl 29):ii5-ii21.
22. Maduell F. Hemodiafiltration. Hemodial Int. 2005;9:47-55.
23. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009;4:1944-1953.
24. Bolasco P, Altieri P, Andrulli S, et al. Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant. 2003;18(Suppl 7):vii50-vii54.
25. Penne EL, Blankestijn PJ, Bots ML, et al. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study. Semin Dial. 2005;18:47-51.
26. Canaud B, Morena M, Leray-Moragues H, Chalabi L, Cristol JP. Overview of clinical studies in hemodiafiltration: what do we need now? Hemodial Int. 2006;10:S5-S12.
27. Ege University. Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis (Turkish HDF study). Clinical-Trials.gov, NIH. Available at: http://clinicaltrials.gov/ct2/show/NCT00411177. Accessed April 30, 2010.